Purple Biotech (PPBT) Other Working Capital Changes (2017 - 2023)
Purple Biotech (PPBT) reported Other Working Capital Changes of -$41000.0 for Q4 2023, down 109.38% year-over-year from $437000.0 in Q4 2022, and up 74.53% quarter-over-quarter from -$161000.0 in Q1 2023.
Purple Biotech (PPBT) Other Working Capital Changes (2017 - 2023) Analysis & Trends
Purple Biotech (PPBT) has 7 years of Other Working Capital Changes data on file, last reported at -$41000.0 in Q4 2023.
- Other Working Capital Changes for Q4 2023 came in at -$41000.0, down 109.38% year-over-year; the trailing twelve-month figure through Dec 2023 was -$202000.0 (down 169.9% YoY), and the FY2025 annual result was $153000.0, up 59.38% from the prior year.
- Other Working Capital Changes rose to -$41000.0 in Q4 2023 per PPBT's latest filing, from -$161000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $848000.0 in Q2 2022 and troughed at -$1.1 million in Q1 2022.
- A 5-year average of -$15666.7 and a median of -$11000.0 in 2020 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2021 and 2022: Other Working Capital Changes sank 736.84% in 2021, then surged 461.16% in 2022.
- A 5-year view of Other Working Capital Changes shows it stood at $22000.0 in 2019, then retreated by 13.64% to $19000.0 in 2020, then slumped by 736.84% to -$121000.0 in 2021, then surged by 461.16% to $437000.0 in 2022, then tumbled by 109.38% to -$41000.0 in 2023.
- Business Quant data shows PPBT's Other Working Capital Changes at -$41000.0 in Q4 2023, -$161000.0 in Q1 2023, and $437000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Purple Biotech | 242.86 Mn | 236.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -41,000.00 |
| Dec 31, 2023 | -41,000.00 |
| Mar 31, 2023 | -161,000.00 |
| Mar 31, 2023 | -161,000.00 |
| Dec 31, 2022 | 437,000.00 |
| Dec 31, 2022 | 437,000.00 |
| Sep 30, 2022 | 138,000.00 |
| Sep 30, 2022 | 138,000.00 |
| Jun 30, 2022 | 848,000.00 |
| Jun 30, 2022 | 848,000.00 |
| Mar 31, 2022 | -1.13 Mn |
| Mar 31, 2022 | -1.13 Mn |
| Dec 31, 2021 | -121,000.00 |
| Dec 31, 2021 | -121,000.00 |
| Sep 30, 2021 | -106,000.00 |
| Sep 30, 2021 | -106,000.00 |
| Jun 30, 2021 | 380,000.00 |
| Jun 30, 2021 | 380,000.00 |
| Mar 31, 2021 | -469,000.00 |
| Mar 31, 2021 | -469,000.00 |